Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.720
+0.120 (7.50%)
At close: Jan 22, 2026
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $386.54 million as of January 22, 2026. Its market cap has decreased by -14.65% in one year.
Market Cap
386.54M
Enterprise Value
219.48M
1-Year Change
-14.65%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $386.54M, a decrease of -86.58%. That is a compound annual growth rate of -24.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 359.57M | 16.79% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 376.77M |
| PepGen | 371.93M |
| Enanta Pharmaceuticals | 362.80M |
| Foghorn Therapeutics | 356.18M |
| Tectonic Therapeutic | 351.96M |
| Aura Biosciences | 348.00M |
| Puma Biotechnology | 347.19M |
| Candel Therapeutics | 345.86M |